CPSC2025-12-18
Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging
MiramarLab, of Doral, Florida
Hazard
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Remedy
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Sold at
Walmart and Target stores nationwide and online at Target.com from April 2024 through October 2025 for about $10.
Affected count
About 50,330
Injuries reported
None reported
Manufactured in
United States
Remedy type
Repair
Products
Mamisan Pain Relieving Topical Ointment
Consumer contact
Plantimex toll-free at 855-752-6869 from 9 a.m. to 4 p.m. PT Monday through Friday, email at customercare@plantimexusa.com with the subject "RECALL" or online at http://plantimexusa.com/contact.php or www.plantimexusa.com and contact us for more information.
Official notice
https://www.cpsc.gov/Recalls/2026/Plantimex-Recalls-Mamisan-Lidocaine-Ointment-Containers-Due-to-Risk-of-Serious-Injury-or-Death-from-Child-Poisoning-Violates-Mandatory-Standard-for-Child-Resistant-PackagingDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief